MedTrace Logo

Pharmaceutical Care in Type 2 Diabetes

NCT01298726 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2011-02-18

No results posted yet for this study

Summary

The purpose of this study is to examine the effect of a pharmaceutical care program on the level of glycated hemoglobin for hyperglycemic users of brazilian public health care system in drug treatment for type 2 diabetes.

Conditions

  • DIABETES MELLITUS, TYPE 2

Interventions

OTHER

PHARMACEUTICAL CARE

The pharmaceutical care program was characterized by face to face monthly visits to collect information, register information, prepare plan of care for every health problem; identification of drug therapy problems, communication to prescribers the drug therapy problems identified and education of participants to resolve the drug therapy problems.

OTHER

HEALTH USUAL CARE

Usual care as defined in health consultations with doctors, nutritionists and nurses, access to laboratory tests and essential medicines

Sponsors & Collaborators

  • Universidade Federal de Ouro Preto

    lead OTHER

Principal Investigators

  • LISIANE S EV, DR · Universidade Federal de Ouro Preto

  • ANDREA G GRABE, DR · Universidade Federal de Ouro Preto

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2010-09-30
Completion
2010-10-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01298726 on ClinicalTrials.gov